Notably, the greater reduction of CBY1 protein compared to transcript suggests that enhanced protein degradation contributes to CBY1 down-modulation in CML hematopoietic progenitors [15]. This evidence concerns the gene CBY1 and chronic myelogenous leukemia, BCR-ABL1 positive.